These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 26942250)

  • 1. Drugs targeting beta-adrenergic receptors: total "selectivity" is elusive.
    Prescrire Int; 2016 Jan; 25(167):9. PubMed ID: 26942250
    [No Abstract]   [Full Text] [Related]  

  • 2. Evidence for coexistence of three beta-adrenoceptor subtypes in human peripheral lymphocytes.
    Yu XY; Lin SG; Wang XM; Liu Y; Zhang B; Lin QX; Yang M; Zhou SF
    Clin Pharmacol Ther; 2007 May; 81(5):654-8. PubMed ID: 17361123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The β3-adrenoceptor mediates the inhibitory effects of β-adrenoceptor agonists via the urothelium in pig bladder dome.
    Masunaga K; Chapple CR; McKay NG; Yoshida M; Sellers DJ
    Neurourol Urodyn; 2010 Sep; 29(7):1320-5. PubMed ID: 20151470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta-adrenoceptor subtypes and their desensitization mechanisms.
    Summers RJ; Kompa A; Roberts SJ
    J Auton Pharmacol; 1997 Dec; 17(6):331-43. PubMed ID: 9610428
    [No Abstract]   [Full Text] [Related]  

  • 5. β1, β2, and β3 adrenoceptors and Na+/H+ exchanger regulatory factor 1 expression in human bronchi and their modifications in cystic fibrosis.
    Bossard F; Silantieff E; Lavazais-Blancou E; Robay A; Sagan C; Rozec B; Gauthier C
    Am J Respir Cell Mol Biol; 2011 Jan; 44(1):91-8. PubMed ID: 20203292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Domains of beta1 and beta2 adrenergic receptors to bind subtype selective agonists.
    Kurose H; Isogaya M; Kikkawa H; Nagao T
    Life Sci; 1998; 62(17-18):1513-7. PubMed ID: 9585128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetrahydroisoquinoline derivatives containing a benzenesulfonamide moiety as potent, selective human beta3 adrenergic receptor agonists.
    Parmee ER; Brockunier LL; He J; Singh SB; Candelore MR; Cascieri MA; Deng L; Liu Y; Tota L; Wyvratt MJ; Fisher MH; Weber AE
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2283-6. PubMed ID: 11055339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of L-755,507: a subnanomolar human beta 3 adrenergic receptor agonist.
    Parmee ER; Ok HO; Candelore MR; Tota L; Deng L; Strader CD; Wyvratt MJ; Fisher MH; Weber AE
    Bioorg Med Chem Lett; 1998 May; 8(9):1107-12. PubMed ID: 9871717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potent, selective benzenesulfonamide agonists of the human beta 3 adrenergic receptor.
    Weber AE; Mathvink RJ; Perkins L; Hutchins JE; Candelore MR; Tota L; Strader CD; Wyvratt MJ; Fisher MH
    Bioorg Med Chem Lett; 1998 May; 8(9):1101-6. PubMed ID: 9871716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Close reciprocal regulation of beta 1- and beta 2-adrenergic receptors by dexamethasone in C6 glioma cells: effects on catecholamine responsiveness.
    Zhong H; Minneman KP
    Mol Pharmacol; 1993 Dec; 44(6):1085-93. PubMed ID: 7903414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-adrenergic receptor subtype-specific signaling in cardiac myocytes from beta(1) and beta(2) adrenoceptor knockout mice.
    Devic E; Xiang Y; Gould D; Kobilka B
    Mol Pharmacol; 2001 Sep; 60(3):577-83. PubMed ID: 11502890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between stereochemistry and the beta3-adrenoceptor agonistic activity of 4'-hydroxynorephedrine derivative as an agent for treatment of frequent urination and urinary incontinence.
    Tanaka N; Tamai T; Mukaiyama H; Hirabayashi A; Muranaka H; Ishikawa T; Kobayashi J; Akahane S; Akahane M
    J Med Chem; 2003 Jan; 46(1):105-12. PubMed ID: 12502364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microdomain switch of cGMP-regulated phosphodiesterases leads to ANP-induced augmentation of β-adrenoceptor-stimulated contractility in early cardiac hypertrophy.
    Perera RK; Sprenger JU; Steinbrecher JH; Hübscher D; Lehnart SE; Abesser M; Schuh K; El-Armouche A; Nikolaev VO
    Circ Res; 2015 Apr; 116(8):1304-11. PubMed ID: 25688144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-adrenoceptor expression in pemphigus foliaceus.
    Miyamoto D; Dias ABT; Aoki V; Burnier MN
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):e459-e461. PubMed ID: 29730879
    [No Abstract]   [Full Text] [Related]  

  • 15. [Current concepts of the physiopathology of coronary beta-adrenergic receptors, and their clinical applications].
    Barbato E; Wijns W; De Bruyne B; Mascia G; Piscione F
    Recenti Prog Med; 2005 Sep; 96(9):411-5. PubMed ID: 16229320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Beta-adrenergic receptors in normal and failing heart].
    Mackiewicz U; Klemenska E; Beresewicz A
    Kardiol Pol; 2007 Mar; 65(3):294-302. PubMed ID: 17436160
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of beta1-, beta2-, and beta3-adrenoceptors in contractile hypersensitivity in a model of small bowel transplantation.
    Rickenbacher A; Seiler R; Honegger U; Shaw SG; Balsiger BM
    Surgery; 2008 Jan; 143(1):94-102. PubMed ID: 18154937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular characterization of the pharmacological selectivity and tachyphylactic properties of denopamine for the human beta adrenergic receptors.
    Suzuki T; Nantel F; Bonin H; Valiquette M; Bouvier M
    J Pharmacol Exp Ther; 1993 Nov; 267(2):785-90. PubMed ID: 7902433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of a potent, orally bioavailable beta(3) adrenergic receptor agonist, (R)-N-[4-[2-[[2-hydroxy-2-(3-pyridinyl)ethyl]amino]ethyl]phenyl]-4-[4 -[4-(trifluoromethyl)phenyl]thiazol-2-yl]benzenesulfonamide.
    Mathvink RJ; Tolman JS; Chitty D; Candelore MR; Cascieri MA; Colwell LF; Deng L; Feeney WP; Forrest MJ; Hom GJ; MacIntyre DE; Miller RR; Stearns RA; Tota L; Wyvratt MJ; Fisher MH; Weber AE
    J Med Chem; 2000 Oct; 43(21):3832-6. PubMed ID: 11052788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective desensitization of beta 1- and beta 2-andrenergic receptors in C6 glioma cells. Effects on catecholamine responsiveness.
    Guerrero SW; Zhong H; Minneman KP
    Receptor; 1995; 5(4):185-95. PubMed ID: 8840397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.